| 37633258 | Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023. | Clin Infect Dis | 2024 |
| 36255273 | Clinical and temporal characterization of COVID-19 subgroups using patient vector embeddings of electronic health records. | J Am Med Inform Assoc | 2023 |
| 37590187 | Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37479609 | Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021. | Vaccine | 2023 |
| 37394267 | Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. | Am J Transplant | 2023 |
| 37181728 | A metadata framework for computational phenotypes. | JAMIA Open | 2023 |
| 37333688 | Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort study. | Lancet Reg Health Am | 2023 |
| 37034358 | Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. | EClinicalMedicine | 2023 |
| 37128466 | Feasibility of Linking Area Deprivation Index Data to the OMOP Common Data Model. | AMIA Annu Symp Proc | 2023 |
| 37026401 | Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents. | Pediatrics | 2023 |
| 36921274 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2023 |
| 36920396 | Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods. | JAMA Netw Open | 2023 |
| 36806690 | Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance. | J Infect Dis | 2023 |
| 36683410 | Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network. | J Infect Dis | 2023 |
| 36935011 | Representing and utilizing clinical textual data for real world studies: An OHDSI approach. | J Biomed Inform | 2023 |
| 36458881 | Association of Longitudinal Activity Measures and Diabetes Risk: An Analysis From the National Institutes of Health All of Us Research Program. | J Clin Endocrinol Metab | 2023 |
| 36415904 | Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022. | J Infect Dis | 2023 |
| 34967121 | Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021. | Am J Transplant | 2022 |
| 35672961 | Harmonization of Measurement Codes for Concept-Oriented Lab Data Retrieval. | Stud Health Technol Inform | 2022 |
| 35345821 | Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS. | Clin Epidemiol | 2022 |
| 35396991 | Comparing medical history data derived from electronic health records and survey answers in the All of Us Research Program. | J Am Med Inform Assoc | 2022 |
| 35854725 | EHR Data Quality Assessment Tools and Issue Reporting Workflows for the 'All of Us' Research Program Clinical Data Research Network. | AMIA Jt Summits Transl Sci Proc | 2022 |
| 35486806 | Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis. | JMIR Public Health Surveill | 2022 |
| 35862287 | Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35358170 | Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36580430 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36106377 | Identification of patients with drug-resistant epilepsy in electronic medical record data using the Observational Medical Outcomes Partnership Common Data Model. | Epilepsia | 2022 |
| 36173371 | An interactive fitness-for-use data completeness tool to assess activity tracker data. | J Am Med Inform Assoc | 2022 |
| 36264840 | Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36191948 | Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. | BMJ | 2022 |
| 36156146 | Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. | JAMA Netw Open | 2022 |
| 36216933 | Association of step counts over time with the risk of chronic disease in the All of Us Research Program. | Nat Med | 2022 |
| 35276502 | Patient characteristics and antiseizure medication pathways in newly diagnosed epilepsy: Feasibility and pilot results using the common data model in a single-center electronic medical record database. | Epilepsy Behav | 2022 |
| 35239634 | Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35176007 | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35085224 | Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 32805036 | The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. | J Am Med Inform Assoc | 2021 |
| 33739294 | Factors Affecting the Quality of Person-Generated Wearable Device Data and Associated Challenges: Rapid Systematic Review. | JMIR Mhealth Uhealth | 2021 |
| 33706377 | Development and validation of prediction models for mechanical ventilation, renal replacement therapy, and readmission in COVID-19 patients. | J Am Med Inform Assoc | 2021 |
| 33725121 | COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. | Rheumatology (Oxford) | 2021 |
| 33749656 | Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave. | J Alzheimers Dis | 2021 |
| 33688639 | Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. | Res Sq | 2021 |
| 34941540 | Identifying Data Quality Dimensions for Person-Generated Wearable Device Data: Multi-Method Study. | JMIR Mhealth Uhealth | 2021 |
| 34911126 | Effect of Electronic Health Record Reminders for Routine Immunizations and Immunizations Needed for Chronic Medical Conditions. | Appl Clin Inform | 2021 |
| 34529642 | Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 34383798 | Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19. | PLoS One | 2021 |
| 34735426 | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 34735425 | Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 34496194 | Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. | N Engl J Med | 2021 |
| 34642696 | A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections - Risk Factors and Vaccine Effectiveness. | medRxiv | 2021 |